journal article·2025-06Open access

Nanoscale piezoelectric patches preserve electrical integrity of infarcted hearts

Luís M. Monteiro, Pedro J. Gouveia, Francisco Vasques-Nóvoa, Susana Rosa, Ifigeneia Bardi, Rita N. Gomes, Simão Correia-Santos, Leonardo Ricotti, Lorenzo Vannozzi, Daniele Guarnera, Liliana Costa, André M. Leite-Moreira, Pedro Mendes-Ferreira, Adelino F. Leite-Moreira, Filippo Perbellini, Cesare M. Terracciano, Perpétua Pinto-do-Ó, Lino Ferreira, Diana S. Nascimento

Abstract

Ischemic heart disease is the leading cause of death worldwide. Several approaches have been explored to restore cardiac function, however few investigated new strategies to improve electrical functional recovery. Herein, we have investigated the impact of piezoelectric patches (Piezo patches), capable of generating electric charges upon mechanical deformation, on rat cardiac slices, healthy and ischemic hearts ( ex vivo ), on infarcted mice ( in vivo ) and on healthy and infarcted pigs ( in vivo ). Piezo patches did not preclude cardiac slice contractility , while compared with electrically inert control patches. In addition, Piezo patches showed an adequate safety profile in a working heart model as no electrophysiologic alterations were detected in healthy hearts. Epicardial implantation of Piezo patches in acutely infarcted mice hearts significantly improved myocardial electrical integrity without disturbing systolic function . Moreover, Piezo patches partially prevented ischemia-related adverse cardiac remodeling , reducing left ventricular chamber dilatation and compensatory hypertrophy. Coherently, Piezo patch-implanted hearts revealed downregulation of genes associated with extracellular matrix remodeling. Importantly, in vivo implantation of Piezo patches in porcine hearts revealed to be electrically safe as no major effects in its electrophysiology were detected. Overall, the results presented here endorse Piezo patches as a promising therapeutic strategy to improve post-myocardial infarction structural and electrical remodeling.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Sensor and Energy Harvesting Materials · Neuroscience and Neural Engineering · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (93)

Show source-provided references
1. Global epidemiology of ischemic heart disease: results from the global burden of disease study
2. Cell therapy trials for heart regeneration - lessons learned and future directions10.1038/s41569-018-0013-0 ↗
3. Native and bioengineered extracellular vesicles for cardiovascular therapeutics10.1038/s41569-020-0389-5 ↗
4. Designing acellular injectable biomaterial therapeutics for treating myocardial infarction and peripheral artery disease10.1016/j.jacbts.2016.11.008 ↗
5. Flexible shape-memory scaffold for minimally invasive delivery of functional tissues10.1038/nmat4956 ↗
6. A conducting polymer with enhanced electronic stability applied in cardiac models10.1126/sciadv.1601007 ↗
7. Auxetic cardiac patches with tunable mechanical and conductive properties toward treating myocardial infarction10.1002/adfm.201800618 ↗
8. Restoring heart function and electrical integrity: closing the circuit10.1038/s41536-017-0015-2 ↗
9. Nanoengineered electroconductive collagen-based cardiac patch for infarcted myocardium repair10.1021/acsami.8b18844 ↗
10. A conductive bioengineered cardiac patch for myocardial infarction treatment by improving tissue electrical integrity10.1002/adhm.202201856 ↗
11. Research progress of electrical stimulation in ischemic heart disease10.3389/fcvm.2021.761877 ↗
12. Implantable cardioverter-defibrillators for secondary prevention of sudden cardiac death: a review10.1161/JAHA.117.005515 ↗
13. Who will benefit from an implantable cardioverter defibrillator?10.1161/CIRCOUTCOMES.119.005995 ↗
14. Piezoelectric biomaterials for sensors and actuators10.1002/adma.201802084 ↗
15. Piezoelectric nanomaterials activated by ultrasound: the pathway from discovery to future clinical adoption10.1021/acsnano.1c03087 ↗
16. Progress in the applications of smart piezoelectric materials for medical devices10.3390/polym12112754 ↗
17. Piezoelectricity as a fundamental property of biological tissues10.1038/213267a0 ↗
18. Nanoscale characterization of isolated individual type I collagen fibrils: polarization and piezoelectricity10.1088/0957-4484/20/8/085706 ↗
19. Piezoelectricity in tendon and bone10.1016/0021-9290(75)90076-7 ↗
20. Multimaterial printing of serpentine microarchitectures with synergistic mechanical/piezoelectric stimulation for enhanced cardiac-specific functional regeneration10.1002/smll.202401561 ↗
21. Piezoelectric materials for tissue regeneration: a review10.1016/j.actbio.2015.07.010 ↗
22. Piezoelectric polymers as biomaterials for tissue engineering applications10.1016/j.colsurfb.2015.08.043 ↗
23. The effect of PVDF-TrFE scaffolds on stem cell derived cardiovascular cells10.1002/bit.25918 ↗
24. Flexible nanofilms coated with aligned piezoelectric microfibers preserve the contractility of cardiomyocytes10.1016/j.biomaterials.2017.05.048 ↗
25. Conformal piezoelectric energy harvesting and storage from motions of the heart, lung, and diaphragm10.1073/pnas.1317233111 ↗
26. Ultra-flexible piezoelectric devices integrated with heart to harvest the biomechanical energy10.1038/srep16065 ↗
27. Electroactive biomaterials and systems for cell fate determination and tissue regeneration: design and applications10.1002/adma.202007429 ↗
28. Gender differences in cardiac function during early remodeling after acute myocardial infarction in mice10.1016/j.lfs.2004.04.024 ↗
29. Guidelines for in vivo mouse models of myocardial infarction10.1152/ajpheart.00459.2021 ↗
30. Molecular and cellular differences in cardiac repair of male and female mice10.1161/JAHA.119.015672 ↗
31. Methods for the determination of rates of glucose and fatty acid oxidation in the isolated working rat heart
32. Preparation of viable adult ventricular myocardial slices from large and small mammals10.1038/nprot.2017.139 ↗
33. Biomimetic electromechanical stimulation to maintain adult myocardial slices in vitro10.1038/s41467-019-10175-3 ↗
34. Myocardial ischemia and reperfusion: a murine model
35. Cardiac mechanics revisited: the relationship of cardiac architecture to ventricular function10.1161/CIRCULATIONAHA.107.754424 ↗
36. MIQuant--semi-automation of infarct size assessment in models of cardiac ischemic injury10.1371/journal.pone.0025045 ↗
37. Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches10.1152/japplphysiol.00033.2007 ↗
38. Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays10.1126/science.1181498 ↗
39. Trimmomatic: a flexible trimmer for Illumina sequence data10.1093/bioinformatics/btu170 ↗
40. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype10.1038/s41587-019-0201-4 ↗
41. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update10.1093/nar/gky379 ↗
42. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update10.1093/nar/gkw377 ↗
43. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool10.1186/1471-2105-14-128 ↗
44. Heatmapper: web-enabled heat mapping for all10.1093/nar/gkw419 ↗
45. Human-umbilical cord matrix mesenchymal cells improved left ventricular contractility independently of infarct size in swine myocardial infarction with reperfusion10.3389/fcvm.2023.1186574 ↗
46. Detecting outliers when fitting data with nonlinear regression - a new method based on robust nonlinear regression and the false discovery rate10.1186/1471-2105-7-123 ↗
47. Myocardial tissue elastic properties determined by atomic force microscopy after stromal cell-derived factor 1alpha angiogenic therapy for acute myocardial infarction in a murine model10.1016/j.jtcvs.2011.12.028 ↗
48. Temperature dependence of the piezoelectric constant of thin PVDF and P(VDF-TrFE) films10.1080/00150199208223338 ↗
49. The cardiac sodium channel gene SCN5A and its gene product NaV1.5: role in physiology and pathophysiology10.1016/j.gene.2015.08.062 ↗
50. Cardiac ion channels in health and disease10.1016/j.hrthm.2009.08.005 ↗
51. Electrical stimulation of neonatal cardiac myocytes activates the NFAT3 and GATA4 pathways and up-regulates the adenylosuccinate synthetase 1 gene10.1074/jbc.275.3.1855 ↗
52. Mouse ECG findings in aging, with conduction system affecting drugs and in cardiac pathologies: development and validation of ECG analysis algorithm in mice
53. Electrophysiological characterization of murine myocardial ischemia and infarction10.1007/s003950170054 ↗
54. Species-dependent mechanisms of cardiac arrhythmia: a cellular focus10.1177/1179546816686061 ↗
55. Electrically conductive poly-$${\upepsilon }$$-caprolactone/polyethylene glycol/multi-wall carbon nanotube nanocomposite scaffolds coated with fibrin glue for myocardial tissue engineering10.1007/s00339-017-1474-4 ↗
56. Cardiac cell therapy fails to rejuvenate the chronically scarred rodent heart10.1161/CIRCULATIONAHA.120.053080 ↗
57. Consistent long-term therapeutic efficacy of human umbilical cord matrix-derived mesenchymal stromal cells after myocardial infarction despite individual differences and transient engraftment10.3389/fcell.2021.624601 ↗
58. Tpeak-to-Tend interval corrected for heart rate: a more precise measure of increased sudden death risk?10.1016/j.hrthm.2016.08.022 ↗
59. Consistency of heart rate-QTc prolongation consistency and sudden cardiac death: the Rotterdam Study10.1016/j.hrthm.2015.07.011 ↗
60. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough?10.1161/01.CIR.0000085658.98621.49 ↗
61. ADAMs family and relatives in cardiovascular physiology and pathology10.1016/j.yjmcc.2015.10.031 ↗
62. Periostin is essential for cardiac healing after acute myocardial infarction10.1084/jem.20071297 ↗
63. Reversion inducing cysteine rich protein with Kazal motifs and cardiovascular diseases: the RECKlessness of adverse remodeling10.1016/j.cellsig.2021.109993 ↗
64. CD44 is critically involved in infarct healing by regulating the inflammatory and fibrotic response10.4049/jimmunol.180.4.2625 ↗
65. Infarct in the heart: what's MMP-9 got to do with it?10.3390/biom11040491 ↗
66. VCAM1 expression in the myocardium is associated with the risk of heart failure and immune cell infiltration in myocardium
67. Human cardiac fibroblasts expressing VCAM1 improve heart function in postinfarct heart failure rat models by stimulating lymphangiogenesis10.1371/journal.pone.0237810 ↗
68. The role of the TGF-beta superfamily in myocardial infarction10.3389/fcvm.2019.00140 ↗
69. Therapeutic targets for the treatment of cardiac fibrosis and cancer: focusing on TGF-beta signaling10.3389/fcvm.2020.00034 ↗
70. A computational screen for regulators of oxidative phosphorylation implicates SLIRP in mitochondrial RNA homeostasis10.1371/journal.pgen.1000590 ↗
71. Small proline-rich protein 1A is a gp130 pathway- and stress-inducible cardioprotective protein10.1038/sj.emboj.7600454 ↗
72. Angiopoietin-like protein 7 and short-term mortality in acute heart failure10.1159/000504879 ↗
73. Recombinant frizzled1 protein attenuated cardiac hypertrophy after myocardial infarction via the canonical Wnt signaling pathway10.18632/oncotarget.23149 ↗
74. Dickkopf-3 protects against cardiac dysfunction and ventricular remodelling following myocardial infarction10.1007/s00395-015-0481-x ↗
75. The extracellular matrix proteoglycan fibromodulin is upregulated in clinical and experimental heart failure and affects cardiac remodeling10.1371/journal.pone.0201422 ↗
76. Wnt signaling in cardiac remodeling and heart failure
77. Overexpression of SerpinE2/protease nexin-1 contribute to pathological cardiac fibrosis via increasing collagen deposition
78. Structure and function of the Nppa-Nppb cluster locus during heart development and disease10.1007/s00018-017-2737-0 ↗
79. Neuregulin-1 induces cardiac hypertrophy and impairs cardiac performance in post-myocardial infarction rats10.1161/CIRCULATIONAHA.119.044313 ↗
80. Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseases10.1016/j.ijcard.2011.06.066 ↗
81. A transgenic mouse model for the simultaneous monitoring of ANF and BNP gene activity during heart development and disease10.1093/cvr/cvt228 ↗
82. The role of endothelial autocrine NRG1/ERBB4 signaling in cardiac remodeling10.1152/ajpheart.00176.2020 ↗
83. Anti-remodeling and anti-fibrotic effects of the neuregulin-1beta glial growth factor 2 in a large animal model of heart failure10.1161/JAHA.113.000773 ↗
84. Neuregulin as a heart failure therapy and mediator of reverse remodeling10.1007/s11897-013-0176-2 ↗
85. Metabolic shifts during cardiac hypertrophy10.2217/clp.09.73 ↗
86. Glucose metabolism in cardiac hypertrophy and heart failure10.1161/JAHA.119.012673 ↗
87. Mechanisms for increased glycolysis in the hypertrophied rat heart10.1161/01.HYP.0000144292.69599.0c ↗
88. Cardiac stromal cell patch integrated with engineered microvessels improves recovery from myocardial infarction in rats and pigs10.1021/acsbiomaterials.0c00942 ↗
89. Large cardiac muscle patches engineered from human induced-pluripotent stem cell-derived cardiac cells improve recovery from myocardial infarction in swine10.1161/CIRCULATIONAHA.117.030785 ↗
90. An off-the-shelf artificial cardiac patch improves cardiac repair after myocardial infarction in rats and pigs10.1126/scitranslmed.aat9683 ↗
91. Cardioprotection of PLGA/gelatine cardiac patches functionalised with adenosine in a large animal model of ischaemia and reperfusion injury: a feasibility study10.1002/term.2875 ↗
92. Animal models of arrhythmia: classic electrophysiology to genetically modified large animals10.1038/s41569-019-0179-0 ↗
93. Advanced cardiac patches for the treatment of myocardial infarction10.1161/CIRCULATIONAHA.123.067097 ↗